Chapter 11. Plasminogen Activators
- 1 January 1985
- book chapter
- Published by Elsevier
- Vol. 20, 107-115
- https://doi.org/10.1016/s0065-7743(08)61037-4
Abstract
No abstract availableThis publication has 99 references indexed in Scilit:
- Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.Circulation, 1984
- Coronary Thrombolysis with Tissue-Type Plasminogen Activator in Patients with Evolving Myocardial InfarctionNew England Journal of Medicine, 1984
- Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology.Circulation, 1984
- Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial InfarctionNew England Journal of Medicine, 1983
- Intracoronary Fibrinolytic Therapy in Acute Myocardial InfarctionNew England Journal of Medicine, 1983
- Tyrosyl residues of two molecular forms of human urinary urokinase: Their ionization mode characterized by spectrophotometric and CD titrations and reactivity with cyanuric fluoride in relation to enzymic activityBiochemical and Biophysical Research Communications, 1982
- Thrombolytic TherapyNew England Journal of Medicine, 1982
- The mechanism of activation of human plasminogen by streptokinaseBiochemical and Biophysical Research Communications, 1971
- Activation of plasminogen by human plasma kallikreinBiochemical and Biophysical Research Communications, 1969
- p-Nitrophenyl-p′-guanidinobenzoate HCl: A new active site titrant for trypsinBiochemical and Biophysical Research Communications, 1967